期刊文献+

肝素剂量反应曲线及肝素用量探讨

Study of the Dose-Response Curve and Recommonded Dose of Heparin in Patients with Congenital Heart Disease
下载PDF
导出
摘要 目的计算非紫绀型先天性心脏病患儿群体化肝素剂量反应曲线及ACT(活化凝血时间)值达到480 s和750 s的最小肝素使用剂量。方法将68例非紫绀型先天性心脏病患儿随机分为六组,进入手术室后常规进行生命体征监测及麻醉,监测并记录生理ACT值。体外循环开始前对六组患儿分别静脉注射肝素钠0.5 mg/kg、1mg/kg、1.5 mg/kg、2 mg/kg、2.5 mg/kg、3 mg/kg,5min后采血监测并记录肝素后ACT值。记录每一位患儿的年龄、体重、身高、血常规、出凝血时间并计算体重指数。结果非紫绀型先天性心脏病患儿群体化肝素剂量反应曲线为ACT=190.38×每公斤体重肝素剂量+114.71(r=0.8991)。使95%的患儿ACT值达到480 s的肝素使用剂量为(1.92±0.13)mg/kg,ACT值达到750 s的肝素使用剂量为(3.34±0.26)mg/kg。结论非紫绀型先天性心脏病患儿ACT值达到480 s的肝素最小推荐使用剂量为2.05 mg/kg,ACT值达到750 s的肝素最小推荐使用剂量为3.60 mg/kg。 OBJECTIVE To draw the dose - reaction curve of heparin of congenital heart disease (CHD) patients and calculate the minimal heparin dose when actived clotting time (ACT) reached to 480 second and 750 second. METH- ODS Sixty- eight CHD patients were assigned randomly into six groups, monitoring and introduction as usual. Physiological ACT was monitored and recorded. Hepain was admitted to the six groups before cardiopulmonary bypass for the dose of 0.5mg/kg, 1 mg/kg, 1.5 mg/kg,2 mg/kg,2.5 mg/kg and 3 mg/kg, ACT was monitored after 300 seconds. The age, weight, height, RBC, Hgb, Hct, Plt, PT, APTT, TT and Fib of every patient were recorded. RESULTS The dose - response curve of heparin in CHD patients was ACT = 190.38 ×( heparin dose per kg) + 114.71 ( r = 0. 8991 ). The heparin dose when the ACT of 95% CHD patients reached to 480 seconds and 750 seconds were 1.92±0.13mg/kg and 3.34± 0.26 mg/kg. CONCLUSION The minimal heparin dose of CHD patients when ACT reaches to 480 second and 750 second are 2.05 mg/kg and 3.60 mg/kg.
作者 杨明 薛玉良
出处 《中国体外循环杂志》 2007年第4期197-199,共3页 Chinese Journal of Extracorporeal Circulation
关键词 肝素 抗凝血 活化凝血时间 体外循环 Heparin Anticoagnlation Activated clotting time Extracorporeal circulation
  • 相关文献

参考文献15

  • 1[1]Paul G,Bruce F,Robert K.临床麻醉学[M].王伟鹏主译.第四版.北京:人民卫生出版社,2004.803.
  • 2[2]Smythe MA.Advances in anticoagulation management:the role of pharmacy[J].Ann Pharmacother,2007,41(3):493-495.
  • 3[3]Vats V,Nutescu EA,Theobald jc,et al.Survey of hospitals for guidelines,policies,and protocols for anticoagulants[J].Am J Health Syst Pharm,2007,64(11):1203-1208.
  • 4纪宏文.体外循环心脏手术后异常出血的原因分析[J].中国循环杂志,1998,13(1):59-60. 被引量:13
  • 5[5]Shuhaibar MN,Hargrove M,Millat MN,et al.How much heparin do we really need to go on pump? A rethink of current pracrices[J].Eur J Cardiothorac Surg,2004,26(5):947-950.
  • 6[6]Jobes DR,Aitken GL,Shaffer GW.Increased acctLracy and precision of heparin and protamine dosing reduces blood loss and tansfusion in patients undergoing primary cardiac operations[J].J Thorac Cardiovasc Surg,1995,110:36-45.
  • 7[7]Bull BS,Korpman RA,Huse WM,et al.Heparin therapy during extracorporeal circulation.I Porblems inherent in existing hepatin protocols[J].J Thorac Cardiovasc Surg,1975,69:674-684.
  • 8[8]Paul G,Bruce F,Robert K.Clinical Anesthesia[M].第四版.北京:人民卫生出版社,2004.804.
  • 9[9]Ball BS,Huse WM,Braaer FS,et al.Heparin therapy during extracorporeal circulation.Ⅱ The use of a dose-response curve to individualize heparin and protamine dosage[J].J Thorac Cardiovasc Surg,1975,69:685-689.
  • 10[10]Giavarina D,Carta M,Fabbri A,et al.Monitoring hish-dose heparin levels by ACT and HMT during extracorporeal circulation:diagnostic accuracy of three compact monitors[J].Perfusion,2002,17(1):23-26.

二级参考文献1

  • 1阮长耿,血栓与止血,1994年,327页

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部